Literature DB >> 6401771

Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.

J Crocker, E L Jones.   

Abstract

Three cases of acute renal toxicity in patients receiving long-term therapy with mitomycin C and 5-fluorouracil are reported. Two of the patients (1 and 3) are from a multicentre trial of adjuvant chemotherapy for gastric carcinoma. All three cases showed extensive fibrin deposition in the kidneys and lungs, the appearances of the renal lesions being similar to those seen in the haemolytic-uraemic syndrome. Two of the three cases had received blood transfusions, and attention is drawn to the possibility that mitomycin C may sensitise the kidneys to minor mismatches. With the increasing use of these antimitotic agents, great vigilance should be exercised with regard to renal function and haemolytic status.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401771      PMCID: PMC498099          DOI: 10.1136/jcp.36.1.24

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.

Authors:  S Krauss; T Sonoda; A Solomon
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

2.  Microangiopathic hemolytic anemia in carcinoma of the stomach.

Authors:  E C Lynch; C L Bakken; T H Casey; C P Alfrey
Journal:  Gastroenterology       Date:  1967-01       Impact factor: 22.682

3.  Renal toxicity in man treated with mitomycin C.

Authors:  K Liu; A Mittelman; E E Sproul; E G Elias
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

4.  Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma.

Authors:  M C Brain; J G Azzopardi; L R Baker; G F Pineo; P D Roberts; J V Dacie
Journal:  Br J Haematol       Date:  1970-02       Impact factor: 6.998

5.  Interstitial lung disease in a patient treated with 5-fluorouracil and mitomycin C.

Authors:  J W Fielding; R A Stockley; V S Brookes
Journal:  Br Med J       Date:  1978-08-26

6.  Interstitial fibrosis in a patient treated with 5-fluorouracil and mitomycin C.

Authors:  J W Fielding; J Crocker; R A Stockley; V S Brookes
Journal:  Br Med J       Date:  1979-09-01

7.  Renal disease after mitomycin C therapy.

Authors:  W T Hanna; S Krauss; R F Regester; W M Murphy
Journal:  Cancer       Date:  1981-12-15       Impact factor: 6.860

8.  Intravascular haemolysis and renal impairment after blood transfusion in two patients on long-term 5-fluorouracil and mitomycin-C.

Authors:  B G Jones; J W Fielding; C E Newman; A Howell; V S Brookes
Journal:  Lancet       Date:  1980-06-14       Impact factor: 79.321

  8 in total
  2 in total

1.  Mitomycin-induced hemolytic uremic kidney. An experimental model in the rat.

Authors:  V Cattell
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

2.  Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report.

Authors:  S Serke; H Riess; H Oettle; D Huhn
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.